Article
Here are my highlights from day four, Monday, of the ACR 2020 Convergence.
Vaccine Immunogenicity with Tofacitinib
All News
Article
Investigations on the efficacy and safety of JAK inhibitors as a therapeutic option in the management of AS are increasing.
Article
The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!
Dr. John Cush
Tweet
#BestACR20Tweets
RT @Janetbirdope : Filgo decreased MRI inflammation of many structures early in Rx in SpA which seems novel says w Maksymowych 5M015 @RheumNow #ACR20 @CRASCRRheum #ACRbest https://t.co/5HQiIettjh https://t.co/NwFMkLIhWw
Dr. John Cush
Tweet
Check out of video by Dr. Rachel Tate ( @uptoTate ) titled "Treat to Target in Spondyloarthritis". #ACR20
https://t.co/7ThVtmguFI https://t.co/on9m0qtse3
Dr. John Cush
Tweet
#BestACR20Tweets
RT @synovialjoints : New mode of action treatment in AS. The SELECT-AXIS 1 showed Upadacitinib 15mg od showed sustained efficacy over 1 year @RheumNow #ACR20 Abstr#2023 #ACRbest https://t.co/Auo3AMNTDw
Dr. John Cush
Tweet
#BestACR20Tweets RT @KDAO2011 : FDA updates 6/16/20 canakinumab for AOSD 5/29/20 ixekizumab for nr-AxSpa 80 mg q4wks 3/9/20 nintedanib for progressive ILD 1/29/20 and 6/16/20 secukinumab nr-axSpa 150 mg q4wks, AS 300 mg SQ q4weeks 1/17/20 belimumab label for black pts removed
Dr. John Cush
Tweet
#BestACR20Tweets
"RT @KDAO2011 : Meta-analysis of studies - 4104 pregnancies axSpa/PsA: higher risk for: preterm labor, small for gestational age, C-section
No change in miscarriage/stillbirth, gest.diabetes
#ACR20, @rheumnow Abstr#1771
https://t.co/xl1YyRPavX"
Dr. John Cush
Tweet
Read Dr. Robert Chao's (@doctorRBC) review of ten abstracts and presentations on spondyloarthritis encompassing a wide range of topics from etiology to diagnosis to treatment from #ACR20. https://t.co/BeG1DMssoU https://t.co/ywbvH7qmHY
Dr. John Cush
Tweet
Our latest article is asking: "Erosions on X-ray: can we delegate this to the computers?" by David Liew ( @drdavidliew) #ACR20
https://t.co/YvKjAWebT9 https://t.co/kIqeX3X0n8
Dr. John Cush
Tweet
Rheumatology Roundup! We share the highlights of the virtual #ACR20 meeting.
https://t.co/WUfpsmuX0g https://t.co/uOScYO9LXr
Dr. John Cush
Tweet
Watch our video with Dr. Petryna ( @DrPetryna) as she discusses inadequate response in spondylitis. #ACR20
https://t.co/TCRoO8qGbs
Dr. John Cush
Tweet
Watch our video titled Pregnancy in Spondyloarthritis. Dr Richard Conway ( @RichardPAConway) interviews Dr. Sinead Maguire about abstract #1323 presented at the #ACR20 annual meeting.
https://t.co/YyWOuiq3jn https://t.co/IdqfbeX8x7
Meral K. El Ramahi, MD
Tweet
Poll results are in! 76% of you take into account the location of bone marrow edema in the SI joint of patients with inflammatory back pain in trying to determine if a patient has SpA! #ACR20 @RheumNow https://t.co/gwySNvfSH5
Janet Pope
Tweet
Filgo decreased MRI inflammation of many structures early in Rx in SpA which seems novel says w Maksymowych 5M015 @RheumNow #ACR20 @CRASCRRheum #ACRbest https://t.co/LOOOn7Hjvp
Olga Petryna
Tweet
@rheumnow #ACR20 abs1535 retrospective study of SI MRI reveals 20% pts w/out spondyloarthritis have BME on an MRI, predominantly in the antero-middle quadrant. Erosions were seen in 31% of healthy patients and in 61% of patients with spondyloarthritis
Robert B Chao, MD
Tweet
Hey Google, does this patient have sacroilitis?
Artificial intelligence model validated for detection of radiographic sacroilitis.
@RheumNow #ACR20 Abs#2018 https://t.co/TDhGKC8ss4
Dr. Antoni Chan
Tweet
What was the effect of COVID-19 in axSpA patients? From @rheum_cat In the early phase of COVID-19 there was a higher levels of stress and anxiety leading to higher BASDAI scores @RheumNow #ACR20 Abstr#1884
Dr. Antoni Chan
Tweet
The majority of patients with axSpA were able to use an axSpA smartphone app. recording BASDAI, BASFI 2 weekly. Current disease activity influence adherence to reporting @RheumNow #ACR20 Abstr#1890
Robert B Chao, MD
Tweet
COX2 inhibitors associated with inhibition of radiographic spinal progression in AxSpA pts compared to non-selective NSAIDs.
⬇️radiographic spinal progression over 2 yrs
⬇️mSASSS progression
@RheumNow #ACR20 Abs#2030 https://t.co/p1CeNBm3ma
